Impact of Risk Minimisation Measures on Citalopram Use in Two European Countries

Sep-15

Pharmacoepidemiology

AUTHORS : Dr Miriam Sturkenboom, Julius Global Health, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands – Email: m.c.j.sturkenboom@umcutrecht.nl – Profile: https://www.umcutrecht.nl/en/research/researchers/sturkenboom-miriam-mcjm

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 24(S1):459-460

DOI : 10.1002/pds.3838

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more